Cargando…

Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”

Detalles Bibliográficos
Autores principales: Nieto-Gómez, Pelayo, Castaño-Amores, Celia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630292/
https://www.ncbi.nlm.nih.gov/pubmed/37707706
http://dx.doi.org/10.1007/s40120-023-00537-x
_version_ 1785146015500730368
author Nieto-Gómez, Pelayo
Castaño-Amores, Celia
author_facet Nieto-Gómez, Pelayo
Castaño-Amores, Celia
author_sort Nieto-Gómez, Pelayo
collection PubMed
description
format Online
Article
Text
id pubmed-10630292
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-106302922023-11-14 Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” Nieto-Gómez, Pelayo Castaño-Amores, Celia Neurol Ther Letter Springer Healthcare 2023-09-14 /pmc/articles/PMC10630292/ /pubmed/37707706 http://dx.doi.org/10.1007/s40120-023-00537-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Nieto-Gómez, Pelayo
Castaño-Amores, Celia
Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
title Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
title_full Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
title_fullStr Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
title_full_unstemmed Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
title_short Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
title_sort letter to the editor regarding: “real-world analysis affirms the high persistence and adherence observed with diroximel fumarate in patients with multiple sclerosis”
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630292/
https://www.ncbi.nlm.nih.gov/pubmed/37707706
http://dx.doi.org/10.1007/s40120-023-00537-x
work_keys_str_mv AT nietogomezpelayo lettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis
AT castanoamorescelia lettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis